Cleveland Heart International will commercialise CU Medical automatic external defibrillators in the USA. In addition to entering the US automatic external defibrillators market, Cleveland Heart International will leverage CU Medical’s manufacturing and engineering capacity to commercialise current company technology covering all stages of heart failure.
“CU Medical is a natural fit for Cleveland Heart International. CU Medical’s technology and manufacturing capacity coupled with our portfolio of medical device properties and US distribution makes for a winning combination,” said Jim Hansberger Jr, president of Cleveland Heart International.
Cleveland Heart International will be commercialising and acquiring cardiovascular medical device technologies over the next 18 months. The company has engaged Westbury Group as its exclusive financial advisor to facilitate equity financing.
